Compare BioNano Genomics Inc (BNGO) vs eBay Inc (EBAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs eBay Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.77M), while eBay Inc trades at $102.72 (market cap $45.53B). The key difference: eBay Inc is far larger — about 3306.5× BioNano Genomics Inc's market cap, and eBay Inc pays a 1.21% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | EBAY | |
|---|---|---|
Market Cap | $13.77M | $45.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $118.96 |
52-Week Low | $1.06 | $79.41 |
Enterprise Value | $16.38M | $49.35B |
Volume | — | 5,186,418 |
Dividend Yield | — | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
EBAY trades at $102.23, down 5.09% amid reports GameStop may abandon its $56 billion takeover bid in favor of a partnership. The stock shows bearish technical signals with support near $104, while fundamentals remain solid with Q2 2026 earnings beating estimates and an 18.57% net income margin. Revenue growth is projected to reach $12.0 billion in 2026, though cash flow turned negative in 2025.
The outlook is mixed: strong execution and a potential partnership or buyout offer present upside, but withdrawal of the bid and insider selling pose near-term risks. Analyst consensus is a $119.31 price target with a buy rating, but investors face volatility from deal uncertainty and competitive pressures in e-commerce.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →
